Discontinued — last reported Q4 '25

Johnson & Johnson R&D increased by 4.4% to $3.67B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 25.8%, from $4.95B to $3.67B. Over 2 years (FY 2021 to FY 2024), R&D shows an upward trend with a 19.0% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

High spending signals a focus on long-term innovation, though it reduces current-period net income.

Detailed definition

Expenses related to the innovation, design, and improvement of products and services. In the technology sector, this rep...

Peer comparison

Big Tech firms often reinvest a significant percentage of revenue into R&D to maintain market leadership.

Metric ID: is_research_and_development

Historical Data

16 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$3.18B$3.39B$3.42B$3.84B$3.46B$3.70B$3.60B$3.56B$3.45B$3.54B$3.44B$4.95B$5.30B$3.23B$3.52B$3.67B
QoQ Change+6.8%+0.8%+12.2%-9.9%+7.0%-2.9%-0.9%-3.3%+2.8%-2.9%+44.0%+7.0%-39.1%+9.0%+4.4%
YoY Change+8.9%+9.1%+5.1%+2.9%-6.9%-3.5%+43.7%-8.9%+2.2%-25.8%
Range$3.18B$5.30B
CAGR+3.9%
Avg YoY Growth+2.7%
Median YoY Growth+2.6%
Current Streak2 quarters growth

Frequently Asked Questions

What is Johnson & Johnson's r&d?
Johnson & Johnson (JNJ) reported r&d of $3.67B in Q3 2025.
How has Johnson & Johnson's r&d changed year-over-year?
Johnson & Johnson's r&d decreased by 25.8% year-over-year, from $4.95B to $3.67B.
What is the long-term trend for Johnson & Johnson's r&d?
Over 2 years (2021 to 2024), Johnson & Johnson's r&d has grown at a 19.0% compound annual growth rate (CAGR), from $12.16B to $17.23B.
What does r&d mean?
Money spent on developing new products and improving existing ones.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.